THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Bellevue Group AG's Holding History (CIK: 0001674546)

Note: Option positions (PUT/CALL) are excluded.

Q4 2017
Shares 10,628 Value ($000) $296 Avg Close $29.59 Range $25.20 - $35.90
Q3 2017
Shares 14,428 Value ($000) $494 Avg Close $32.70 Range $23.15 - $42.61
Q2 2017
Shares 14,428 Value ($000) $575 Avg Close $38.45 Range $34.85 - $43.44
Q1 2017
Shares 14,428 Value ($000) $531 Avg Close $31.95 Range $27.80 - $37.18
Q4 2016
Shares 15,428 Value ($000) $492 Avg Close $31.02 Range $24.54 - $38.92
Q3 2016
Shares 18,428 Value ($000) $668 Avg Close $27.84 Range $21.97 - $37.14
Q2 2016
Shares 11,428 Value ($000) $259 Avg Close $21.59 Range $15.00 - $24.76
Q1 2016
Shares 11,248 Value ($000) $215 Avg Close $16.36 Range $12.87 - $19.00